These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12745610)

  • 21. Therapy development for ALS: lessons learned and path forward.
    Lanka V; Cudkowicz M
    Amyotroph Lateral Scler; 2008 Jun; 9(3):131-40. PubMed ID: 18574756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Commentary on 'a novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS'.
    Shefner JM; Nigel Leigh P
    Amyotroph Lateral Scler; 2008 Aug; 9(4):254-6. PubMed ID: 18642137
    [No Abstract]   [Full Text] [Related]  

  • 23. Measures of quality of life: pro.
    Ludolph AC
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S19. PubMed ID: 12396796
    [No Abstract]   [Full Text] [Related]  

  • 24. Can we eliminate placebo in ALS clinical Trials?
    Simmons Z
    Muscle Nerve; 2009 Jun; 39(6):861-5. PubMed ID: 19382170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Minocycline for the treatment of amyotrophic lateral sclerosis: neuroprotector or neurotoxin? Reflections on another failure of translational medicine].
    Gámez J
    Neurologia; 2008 Oct; 23(8):484-93. PubMed ID: 18802797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ALS lessons learned from other neurological diseases. Neuro-oncology.
    Schold SC
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():34-5. PubMed ID: 15512867
    [No Abstract]   [Full Text] [Related]  

  • 27. [Update on fundamental and clinical research in amyotrophic lateral sclerosis].
    Pradat PF; Camdessanché JP; Carluer L; Cintas P; Corcia P; Danel-Brunaud V; Echaniz-Laguna A; Gonzalez J; Nicolas G; Vandenberghe N; Verschueren A;
    Rev Neurol (Paris); 2009; 165(6-7):532-41. PubMed ID: 19419744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline disease characteristics.
    Leigh PN
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():64-7. PubMed ID: 15512877
    [No Abstract]   [Full Text] [Related]  

  • 29. Outcome measures for early phase clinical trials.
    Gordon PH; Cheng B; Montes J; Doorish C; Albert SM; Mitsumoto H
    Amyotroph Lateral Scler; 2007 Oct; 8(5):270-3. PubMed ID: 17852017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving efficiency of ALS clinical trials using lead-in designs.
    Moore DH; Miller RG
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():57-60. PubMed ID: 15512875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
    de Carvalho M; Swash M
    Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving efficiency of ALS clinical trials: a sponsor's perspective.
    Markabi S; Schadrack J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S7-8. PubMed ID: 12396792
    [No Abstract]   [Full Text] [Related]  

  • 33. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
    Dib M
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy in amyotrophic lateral sclerosis.
    Distad BJ; Meekins GD; Liou LL; Weiss MD; Carter GT; Miller RG
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):633-51, xi-xii. PubMed ID: 18625421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-drug therapy in amyotrophic lateral sclerosis: the case for a multi-drug approach.
    Rosenfeld J
    Muscle Nerve; 2004 Nov; 30(5):673-5. PubMed ID: 15452840
    [No Abstract]   [Full Text] [Related]  

  • 36. ALS issues in clinical trials. Statistical issues.
    Levin B
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():43-5. PubMed ID: 15512870
    [No Abstract]   [Full Text] [Related]  

  • 37. A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS.
    Scelsa SN; MacGowan DJ; Mitsumoto H; Imperato T; LeValley AJ; Liu MH; DelBene M; Kim MY
    Neurology; 2005 Apr; 64(7):1298-300. PubMed ID: 15824372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized control trials in ALS: lessons learned.
    Mitsumoto H; Gordon P; Kaufmann P; Gooch CL; Przedborski S; Rowland LP
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():8-13. PubMed ID: 15512861
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical research. ALS trial raises questions about promising drug.
    Couzin J
    Science; 2007 Nov; 318(5854):1227. PubMed ID: 18033854
    [No Abstract]   [Full Text] [Related]  

  • 40. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Levin BJ; Thompson G; Mitsumoto LH; Kaufmann P
    Neurology; 2006 Jun; 66(11):1786-7; author reply 1786-7. PubMed ID: 16769973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.